MEIRAGTX
DEAD

Serial Number

87304368

Owner

MeiraGTx Limited

Attorney

Michael J. Leonard

Filing Date

Jan 17, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MEIRAGTX Trademark

Serial Number: 87304368 • Registration: 5527437

MEIRAGTX is a trademark filed by MeiraGTx Limited on January 17, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

MeiraGTx Limited (2 trademarks)

92 Britannia Walk
London N17NQ , GB

Entity Type: 16

Trademark Details

Filing Date

January 17, 2017

Registration Date

July 31, 2018

Published for Opposition

May 15, 2018

Cancellation Date

February 14, 2025

Goods & Services

Custom manufacture of human therapeutics, pharmaceuticals, biologicals and biopharmaceuticals

Pharmaceutical products for use in gene therapy; pharmaceutical and biological preparations for the treatment of neurological and neurodegerative diseases, ocular diseases and rare diseases, in the nature of rare kidney diseases, rare cardiovascular diseases, rare hepato-gastro-enterological diseases, rare immunodeficiencies, developmental defects, neuromuscular diseases, rare neurological diseases, rare cardiovascular diseases, rare lung diseases, rare bone diseases, rare sensory disorders, rare skin diseases, rare diseases of connective tissue, rare endocrine diseases, rare hereditary metabolic diseases, rare nonmalignant hematologic disorders; pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases

Chemical additives, namely, chemical auxiliary agents, carriers and substances for use in the manufacture of pharmaceutical preparations

Scientific research in the field of genetics, gene therapy and genetic engineering; Genetic testing for scientific research purposes; scientific advisory services relating to gene therapy research; Scientific, biological, pharmaceutical and medical research and services; laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; biochemical and biotechnological analysis and services

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 14, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 31, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 31, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 15, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 15, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 25, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 9, 2018 CRFA
ASSIGNED TO LIE
Apr 5, 2018 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 23, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 25, 2017 GNFN
FINAL REFUSAL E-MAILED
Oct 25, 2017 GNFR
FINAL REFUSAL WRITTEN
Oct 25, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 12, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 12, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 12, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2017 NWOS
NEW APPLICATION ENTERED
Jan 20, 2017 NWAP